| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jan―05 |
SARS-CoV-2 breakthrough infection among people with and without HIV in Ontario, Canada |
Cassandra Freitas, Curtis L. Cooper, Abigail E. Kroch, Sarah A. Buchan, Rahim Moineddin, Gordon Arbess, Anita C. Benoit, Catharine Chambers, Muluba Habanyama, Claire E. Kendall, Jeffrey C. Kwong, Lawrence Mbuagbaw, John McCullagh, Nasheed Moqueet, Devan Nambiar, Vanessa Tran, Sharon Walmsley, Ann N. Burchell |
| 2 |
[GO] |
2025―Nov―14 |
COVID-19 as a natural experiment intervention to reduce new HIV infections among Australian MSM |
Van Thi Ha Nghiem, Ronald Scott Braithwaite |
| 3 |
[GO] |
2025―Sep―15 |
Evaluating the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia |
Rongxing Weng, Jisoo A. Kwon, Mo Hammoud, Brent Clifton, Nick Scott, Skye Mcgregor, Richard T. Gray |
| 4 |
[GO] |
2025―Aug―14 |
Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform |
Seth Inzaule, Ronaldo Silva, Nathan Ford, Soe Soe Thwin, Jassat Waasila, Alimuddin Zumla, Meg Doherty, Janet Diaz, Silvia Bertagnolio |
| 5 |
[GO] |
2025―Aug―04 |
The HIV/AIDS pandemic: where are we now? |
Chris Beyrer, Jirair Ratevosian, Huub Gelderblom, Nora E. Rosenberg |
| 6 |
[GO] |
2025―Jun―18 |
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial |
Kris Hage, Anders Boyd, Udi Davidovich, Ellen Generaal, Elske Hoornenborg, Paul Zantkuijl, Marc Van Der Valk, Dominique Verhagen, Janneke Stalenhoef, Jan Den Hollander, Eliane Leyten, Tania Mudrikova, Hayette Rougier, Thibault Chiarabini, Marc-Antoine Valantin, Gilles Pialoux, Pauline Campa, Janke Schinkel, Karine Lacombe, Maria Prins |
| 7 |
[GO] |
2025―May―08 |
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection |
Sabrina Marozin, Valeria Bono, Martina Mazzoccoli, Matteo Augello, Roberta Rovito, Lucia Taramasso, Antonio Di Biagio, Annapaola Callegaro, Franco Maggiolo, Elisa Borghi, Camilla Tincati, Giulia Marchetti |
| 8 |
[GO] |
2025―Apr―25 |
Outcomes of children living with HIV during the COVID-19 pandemic in Vietnam |
Dewi K. Wati, Lam V. Nguyen, Du T. Quy, Dinh Q. Nguyen, Oanh N. Le, Azar Kariminia |
| 9 |
[GO] |
2025―Mar―13 |
SARS-CoV-2 antibody prevalence in adults living with HIV |
Mary Lucey, Fiona Burns, Sanjay Bhagani, Marc Lipman, Sara Madge, Margaret Johnson, Jennifer Hart, Colette Smith, Dimitra Peppa, Tristan J. Barber |
| 10 |
[GO] |
2025―Jan―29 |
Contextual factors related to the overlap of the overdose and HIV pandemics and their clinical implications |
Karl Goodkin, Harold A. Pollack |
| 11 |
[GO] |
2024―Dec―30 |
The challenge of normalizing vaccine behaviors in the postpandemic era |
Christina Wiesmann, Brian Conway |
| 12 |
[GO] |
2024―Nov―29 |
Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model |
Heather Bradley, Nicole Luisi, Anastasia Carter, Terri D. Pigott, Daniela Abramovitz, Sean T. Allen, Alice Asher, Chelsea Austin, Tyler S. Bartholomew, Marianna Baum, Amy Board, Basmattee Boodram, Annick Borquez, Kathryn A. Brookmeyer, Kate Buchacz, Janet Burnett, Hannah L.F. Cooper, Nicole Crepaz, Kora Debeck, Judith Feinberg, Chunki Fong, Edward Freeman, Nathan Woo Furukawa, Becky Genberg, Pamina Gorbach, Holly Hagan, Kanna Hayashi, Emalie Huriaux, Hermione Hurley, Jeanne Keruly, Kathleen Kristensen, Shenghan Lai, Natasha K. Martin, Pedro Mateu-Gelabert, Gregory M. Mcclain, Shruti Mehta, Wing Yin Mok, Marley Reynoso, Steffanie Strathdee, Nicole Torigian, Chenziheng Allen Weng, Ryan Westergaard, April Young, Don C. Des Jarlais |
| 13 |
[GO] |
2024―Nov―22 |
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa |
Emmanuelle Papot, Tamara TOVAR-SANCHEZ, Joana WOODS, Guillaume Thaurignac, Nnakelu Eriobu, Margaret Borok, Richard Kaplan, Anchalee Avihingsanon, Iskandar Azwa, Beatriz Grinsztejng, Nagalingeswaran Kumarasamy, Simiso Sokhela, Mireille Mpoudi-Etame, Maria Arriaga, Simone Jacoby, Gail V. Matthews, Marcelo H. Losso, Saye Khoo, Alexandra Calmy, Charles Kouanfack, Ahidjo Ayouba, Kathy Petoumenos, W.D.Francois Venter, Eric Delaporte, Mark N. Polizzotto |
| 14 |
[GO] |
2024―Nov―14 |
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes |
Louise Bering, Line Dam Heftdal, Safura-Luise Heidari, Sebastian Rask Hamm, Cecillie Bo Hansen, Dina Leth Møller, Mia Pries-Heje, Kamille Fogh, Rasmus Bo Hasselbalch, Laura Pérez-Alós, Jan Gerstoft, Thomas Benfield, Selina Kikkenborg Berg, Anne Vinggaard Christensen, Nina Marie Birk, Linda Maria Hilsted, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Erik Sørensen, Kirsten Grønbæk, Henning Bundgaard, Kasper Iversen, Peter Garred, Susanne Dam Nielsen |
| 15 |
[GO] |
2024―Nov―05 |
Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort |
M. Reuel Friedman, Gina Wingood, Kristen D. Krause, Sarah Krier, Gypsyamber D'souza, Mirjam-Colette Kempf, Matthew J. Mimiaga, Jenn Kwait, Deborah Jones, Jeremy Martinson, Ernesto T. Marques, Phyllis Tien, Kathryn Anastos, Catalina Ramirez, Mardge Cohen, Marlene Camacho-Rivera, Lakshmi Goparaju, Charles R. Rinaldo |
| 16 |
[GO] |
2024―Oct―30 |
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV |
Matteo Augello, Valeria Bono, Roberta Rovito, Andrea Santoro, Camilla Tincati, Giulia Marchetti |
| 17 |
[GO] |
2024―Aug―29 |
Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy |
Tiurlina Siregar, Rebeka Konstantina Weriditi, Yansen Alberth Reba, M. Zaenul Muttaqin, Yovian Yustiko Prasetya |
| 18 |
[GO] |
2024―Jul―11 |
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves |
Catharine Chambers, Curtis L. Cooper, Abigail E. Kroch, Sarah A. Buchan, Claire E. Kendall, Jeffrey C. Kwong, Rahim Moideddin, Lena Nguyen, Gordon Arbess, Anita C. Benoit, Cecilia T. Costiniuk, Muluba Habanyama, Naveed Z. Janjua, Marc-André Langlois, John McCullagh, Lawrence Mbuagbaw, Nasheed Moqueet, Devan Nambiar, Sergio Rueda, Hasina Samji, Vanessa Tran, Sharon Walmsley, Aslam Anis, Ann N. Burchell |
| 19 |
[GO] |
2024―May―30 |
Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum |
|
| 20 |
[GO] |
2024―May―24 |
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands |
Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, Rory D. de Vries, Corine H. Geurtsvankessel, Kathryn S. Hensley, Roos S.G. Sablerolles, Susanne Bogers, Lennert Gommers, Blerdi Blakaj, Pedro Miranda Afonso, Bettina E. Hansen, Bart J.A. Rijnders, Kees Brinkman, P. Hugo M. van der Kuy, Anna H.E. Roukens, Casper Rokx |
| 21 |
[GO] |
2024―Apr―05 |
Vespers: A nursing origin story set in the dawn of the HIV pandemic |
Emily Anne Barr |
| 22 |
[GO] |
2024―Jan―15 |
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size |
Maggie C. Duncan, F. Harrison Omondi, Natalie N. Kinloch, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, Tanya Lawson, Mari L. DeMarco, Janet Simons, Daniel T. Holmes, Christopher F. Lowe, Nic Bacani, Paul Sereda, Rolando Barrios, Marianne Harris, Marc G. Romney, Julio S.G. Montaner, Chanson J. Brumme, Mark A. Brockman, Zabrina L. Brumme |
| 23 |
[GO] |
2024―Jan―09 |
How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico |
Fernando Macías-González, Heleen Vermandere, Alicia Piñeirúa-Menendez, Sergio Bautista-Arredondo |
| 24 |
[GO] |
2024―Jan―03 |
The association of Changes In Depression Severity After The Onset of The Covid-19 Pandemic and Viral Non-Suppression Among People With HIV |
Tarfa Verinumbe, Catherine R. Lesko, Richard D. Moore, Anthony T. Fojo, Jeanne Keruly, LaQuita N. Snow, Heidi Hutton, Geetanjali Chander, Jarratt D. Pytell, Oluwaseun Falade-Nwulia |
| 25 |
[GO] |
2023―Nov―21 |
Individuals with HIV Are Likely Targets for Long COVID |
Iulia Filip |
| 26 |
[GO] |
2023―Nov―15 |
False-positive HIV screening tests during the COVID-19 pandemic, a passing trend? |
Rinat Lasmanovich, Dor Atias, Orna Mor, Uri Obolski |
| 27 |
[GO] |
2023―Nov―08 |
Impact of COVID-19-related clinic closures on HIV incidence in a multicentre study of young adult MSM and transgender women in Kenya |
Elizabeth Wahome, Fredrick O. Otieno, Joshua Kimani, Anders Boyd, Duncan Okall, Joseph Nzioka, Evans Gichuru, Elise van der Elst, Supriya D. Mehta, Robert C. Bailey, Susan M. Graham, Eduard J. Sanders |
| 28 |
[GO] |
2023―Oct―13 |
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1 |
Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, Annette Audigé, Selina Epp, Marcel P. Stoeckle, Anna L. Eichenberger, Alain Amstutz, Christof M. Schoenenberger, Barbara Hasse, Dominique L. Braun, Andri Rauch, Alexandra Trkola, Matthias Briel, Heiner C. Bucher, Huldrych F. Günthard, Benjamin Speich, Irene A. Abela |
| 29 |
[GO] |
2023―Aug―30 |
Outcomes of coronavirus disease 2019-related hospitalization among people with HIV: historical cohort from the Greater Paris area multicenter hospital data warehouse |
Valérie Pourcher, Florence Tubach, Antoine Rozes, Samia Boussouar, Candice Estellat |
| 30 |
[GO] |
2023―Aug―03 |
More evidence for inequitable COVID-19 outcomes in people with HIV |
Laura Waters, Ian Woolley |
| 31 |
[GO] |
2023―Aug―03 |
Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328) |
Cecilia T. Costiniuk, Joel Singer, Terry Lee, Yannick Galipeau, Pauline S. McCluskie, Corey Arnold, Marc-André Langlois, Judy Needham, Mohammad-Ali Jenabian, Ann N. Burchell, Hasina Samji, Catharine Chambers, Sharon Walmsley, Mario Ostrowski, Colin Kovacs, Darrell H.S. Tan, Marianne Harris, Mark Hull, Zabrina L. Brumme, Hope R. Lapointe, Mark A. Brockman, Shari Margolese, Enrico Mandarino, Suzanne Samarani, Branka Vulesevic, Bertrand Lebouche, Jonathan B. Angel, Jean-Pierre Routy, Curtis L. Cooper, Aslam H. Anis |
| 32 |
[GO] |
2023―Jul―14 |
Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters |
Ali Ahmad, Suzanne Samarani, Cecilia T. Costiniuk |
| 33 |
[GO] |
2023―Jul―14 |
Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe |
|
| 34 |
[GO] |
2023―Jul―03 |
Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people |
Nicola Abrescia |
| 35 |
[GO] |
2023―Jul―03 |
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
Myrthe L. Verburgh, Marc van der Valk, Bart J.A. Rijnders, Peter Reiss, Ferdinand W.N.M. Wit |
| 36 |
[GO] |
2023―Jun―01 |
Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV |
Rui Jiang, Jianjun Sun, Bihe Zhao, Renfang Zhang, Li Liu, Jun Chen |
| 37 |
[GO] |
2023―May―18 |
COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study |
Ferdinand WNM Wit, Peter Reiss, Bart Rijnders, Casper Rokx, Anna Roukens, Kees Brinkman, Marc van der Valk |
| 38 |
[GO] |
2023―May―18 |
Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection |
Matteo Augello, Valeria Bono, Roberta Rovito, Camilla Tincati, Antonella D’arminio Monforte, Giulia Marchetti |
| 39 |
[GO] |
2023―May―17 |
Cognitive concerns are a risk factor for mortality in people with human immunodeficiency virus and COVID-19 |
Douglas R. Wilcox, Emily A. Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, Aayushee Jain, Haitham Alabsi, Brody Foy, Virginia A. Triant, Gregory K. Robbins, M. Brandon Westover, Sudeshna Das, Shibani S. Mukerji |
| 40 |
[GO] |
2023―Apr―18 |
Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis |
David WJ Griffin, Rekha Pai Mangalore, Jennifer F Hoy, James H Mcmahon |
| 41 |
[GO] |
2023―Mar―15 |
Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals |
Bin Su, Guido Vanham |
| 42 |
[GO] |
2023―Feb―15 |
SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART |
Peter K. Cheung, Hope R. Lapointe, Yurou Sang, Siobhan Ennis, Francis Mwimanzi, Sarah Speckmaier, Evan Barad, Winnie Dong, Richard Liang, Janet Simons, Christopher F. Lowe, Marc G. Romney, Chanson J. Brumme, Masahiro Niikura, Mark A. Brockman, Zabrina L. Brumme |
| 43 |
[GO] |
2023―Feb―13 |
Increased risk of false positive HIV ELISA results after COVID-19 |
Laura G. Alfie, Yesica S. Longueira, Mónica Pippo, Leonel Cruces, María F. Quiroga, Gabriela Turk, Natalia Laufer |
| 44 |
[GO] |
2023―Feb―13 |
An estimate of excess deaths among people with HIV during the COVID-19 pandemic in the United States, 2020 |
Weiming Zhu, Ya-lin A. Huang, Ruiguang Song, Jeffrey Wiener, Robyn N. Neblett-Fanfair, Athena P. Kourtis, Karen W. Hoover |
| 45 |
[GO] |
2023―Feb―13 |
Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV |
José L. Casado, Pilar Vizcarra, Sara Martín-Colmenarejo, Judith del Pino, Sandra Gomez-Maldonado, Adrían Martín-Hondarza, Alejandro Vallejo |
| 46 |
[GO] |
2023―Feb―02 |
Adverse events and SARS-CoV-2 antibody responses after immunization with sputnik V, ChAdOx1-S and BBIBP-CorV vaccines in people with HIV |
Romina Mauas, Analia Ureña, Diego Cecchini, Maria L. Strada, Soledad Arietti, Isabel Cassetti, Nicholas F. Nogueira, Ana S. Salazar, Violeta J. Rodriguez, Deborah L. Jones, Maria L. Alcaide |
| 47 |
[GO] |
2023―Feb―01 |
The impact of COVID-19 pandemic on the dynamic HIV care engagement among people with HIV: real-world evidence |
Xueying Yang, Jiajia Zhang, Shujie Chen, Sharon Weissman, Bankole Olatosi, Xiaoming Li |
| 48 |
[GO] |
2023―Jan―25 |
COVID-19 vaccine immunogenicity in people with HIV: Erratum |
|
| 49 |
[GO] |
2022―Dec―22 |
Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART |
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, Evan Barad, Nadia Moran-Garcia, Sneha Datwani, Maggie C. Duncan, Rebecca Kalikawe, Siobhan Ennis, Landon Young, Bruce Ganase, F. Harrison Omondi, Gisele Umviligihozo, Winnie Dong, Junine Toy, Paul Sereda, Laura Burns, Cecilia T. Costiniuk, Curtis Cooper, Aslam H. Anis, Victor Leung, Daniel Holmes, Mari L. Demarco, Janet Simons, Malcolm Hedgcock, Natalie Prystajecky, Christopher F. Lowe, Marc G. Romney, Rolando Barrios, Silvia Guillemi, Chanson J. Brumme, Julio S.G. Montaner, Mark Hull, Marianne Harris, Masahiro Niikura, Mark A. Brockman, Zabrina L. Brumme |
| 50 |
[GO] |
2022―Dec―21 |
Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 51 |
[GO] |
2022―Dec―08 |
COVID-19 vaccine immunogenicity in people with HIV |
Cecilia T. Costiniuk, Joel Singer, Terry Lee, Marc-André Langlois, Corey Arnold, Yannick Galipeau, Judy Needham, Iva Kulic, Mohammad-Ali Jenabian, Ann N. Burchell, Hasina Shamji, Catharine Chambers, Sharon Walmsley, Mario Ostrowski, Colin Kovacs, Darrell H.S. Tan, Marianne Harris, Mark Hull, Zabrina L. Brumme, Hope R. Lapointe, Mark A. Brockman, Shari Margolese, Enrico Mandarino, Suzanne Samarani, Branka Vulesevic, Bertrand Lebouché, Jonathan B. Angel, Jean-Pierre Routy, Curtis L. Cooper, Aslam H. Anis |
| 52 |
[GO] |
2022―Dec―08 |
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa |
William C. McMahon, Gaurav Kwatra, Alane Izu, Anthonet L. Koen, Johann Greffrath, Lee Fairlie, Faeezah Patel, Christian K. Mukendi, Nkululeko J. Mbele, Rushil Lala, Wendy A. Burgers, Marta C. Nunes, Clare L. Cutland, Sarah C. Gilbert, Teresa Lambe, Andrew J. Pollard, Shabir A. Madhi |
| 53 |
[GO] |
2022―Nov―16 |
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection |
Julia Del Amo, Rosa Polo, Santiago Moreno, Esteban Martínez, Alfonso Cabello, José Antonio Iribarren, Adria Curran, Juan Macías, Marta Montero, Carlos Dueñas, Ana I. Mariño, Santiago Pérez de la Cámara, Asuncion Díaz, José Ramón Arribas, Inma Jarrín, Miguel A. Hernán |
| 54 |
[GO] |
2022―Oct―18 |
COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV |
Catharine Chambers, Hasina Samji, Curtis L. Cooper, Cecilia T. Costiniuk, Naveed Z. Janjua, Abigail E. Kroch, Gordon Arbess, Anita C. Benoit, Sarah A. Buchan, Hannah Chung, Claire E. Kendall, Jeffrey C. Kwong, Marc-André Langlois, Samantha M. Lee, Lawrence Mbuagbaw, John Mccullagh, Rahim Moineddin, Devan Nambiar, Sharon Walmsley, Aslam Anis, Ann N. Burchell |
| 55 |
[GO] |
2022―Sep―21 |
Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study |
Line D. Rasmussen, Susan Cowan, Jan Gerstoft, Gitte Kronborg, Isik S. Johansen, Carsten S. Larsen, Lothar Weise, Michael Dalager-Pedersen, Steffen Leth, Lars N. Nielsen, Suzanne Lunding, Lars H. Omland, Niels Obel |
| 56 |
[GO] |
2022―Sep―16 |
The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age |
Caitlin A. Moran, Nora T. Oliver, Brittany Szabo, Lauren F. Collins, Minh Ly T. Nguyen, N. Sarita Shah, Abeer Moanna, Jonathan A. Colasanti, Valeria D. Cantos, Wendy S. Armstrong, Anandi N. Sheth, Ighovwerha Ofotokun, Colleen F. Kelley, Vincent C. Marconi, Cecile D. Lahiri |
| 57 |
[GO] |
2022―Sep―02 |
Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors’ reply |
Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Shui Shan Lee, Denise P.C. Chan |
| 58 |
[GO] |
2022―Sep―02 |
Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 59 |
[GO] |
2022―Aug―11 |
Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection |
Marta C. Nunes, Stephanie Jones, Zanele Ditse, Kelly da Silva, Natali Serafin, Renate Strehlau, Amy Wise, Megan Burke, Vuyelwa Baba, Vicky L. Baillie, Ayanda Nzimande, Nwabisa Jafta, Mary Adam, Philiswa Mlandu, Mpolokeng Melamu, Juliette Phelp, Charles Feldman, Yasmin Adam, Shabir A. Madhi, Gaurav Kwatra |
| 60 |
[GO] |
2022―Jul―25 |
Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV |
Frédérique Chammartin, Katharina Kusejko, Chloé Pasin, Alexandra Trkola, Matthias Briel, Patrizia Amico, Marcel P. Stoekle, Anna L. Eichenberger, Barbara Hasse, Dominique L. Braun, Macé M. Schuurmans, Thomas F. Müller, Michael Tamm, Nicolas J. Mueller, Andri Rauch, Michael T. Koller, Huldrych F. Günthard, Heiner C. Bucher, Benjamin Speich, Irene A. Abela |
| 61 |
[GO] |
2022―Jul―22 |
Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection |
Michael J. Peluso, Matthew A. Spinelli, Tyler-Marie Deveau, Carrie A. Forman, Sadie E. Munter, Sujata Mathur, Alex F. Tang, Scott Lu, Sarah A. Goldberg, Mireya I. Arreguin, Rebecca Hoh, Viva Tai, Jessica Y. Chen, Enrique O. Martinez, Brandon C. Yee, Ahmed Chenna, John W. Winslow, Christos J. Petropoulos, Alessandro Sette, Daniella Weiskopf, Nitasha Kumar, Kara L. Lynch, Peter W. Hunt, Matthew S. Durstenfeld, Priscilla Y. Hsue, J. Daniel Kelly, Jeffrey N. Martin, David V. Glidden, Monica Gandhi, Steven G. Deeks, Rachel L. Rutishauser, Timothy J. Henrich |
| 62 |
[GO] |
2022―Jul―18 |
Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV |
Guilin Li, Lesley S. Park, Sara Lodi, Roger W. Logan, Emily J. Cartwright, Lydia Aoun Barakat, Juan P. Casas Romero, Barbra A. Dickerman, Christopher T. Rentsch, Amy C. Justice, Miguel A. Hernán |
| 63 |
[GO] |
2022―Jul―18 |
Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021 |
Weiming Zhu, Ya-lin A. Huang, Jeffrey Weiner, Robyn Neblett-Fanfair, Athena P. Kourtis, H. Irene Hall, Karen W. Hoover |
| 64 |
[GO] |
2022―Jul―14 |
Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV |
Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss, Evan J. Beck, Tihitina Y. Aytenfisu, Trevor S. Johnston, Oliver Laeyendecker, Andrea L. Cox, Joel N. Blankson |
| 65 |
[GO] |
2022―Jul―14 |
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? |
Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, Christof Stingone, Martina Pontone, Anna Rita Buonomini, Massimo Giuliani, Fulvia Pimpinelli, Aldo Morrone, Alessandra Latini |
| 66 |
[GO] |
2022―Jun―28 |
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States |
Rachel A. Bender Ignacio, Adrienne E. Shapiro, Robin M. Nance, Bridget M. Whitney, Joseph A.C. Delaney, Laura Bamford, Darcy Wooten, Maile Y. Karris, William C. Mathews, Hyang Nina Kim, Jeanne Keruly, Greer Burkholder, Sonia Napravnik, Kenneth H. Mayer, Jeffrey Jacobson, Michael Saag, Richard D. Moore, Joseph J. Eron, Amanda L. Willig, Katerina A. Christopoulos, Jeffrey Martin, Peter W. Hunt, Heidi M. Crane, Mari M. Kitahata, Edward R. Cachay |
| 67 |
[GO] |
2022―Jun―22 |
Intersecting epidemics: the impact of COVID-19 on the HIV prevention and care continua in the United States |
Camille E. Spears, Barbara S. Taylor, Albert Y. Liu, Sera M. Levy, Ellen F. Eaton |
| 68 |
[GO] |
2022―Jun―22 |
Long-lasting adaptive Immune memory specific to SARS-CoV-2 in convalescent COVID-19 Stable People living with HIV |
Laura Donadeu, Juan Manuel Tiraboschi, Sofía Scévola, Alba Torija, Maria Meneghini, Thomas Jouve, Alexandre Favà, Laura Calatayud, Carmen Ardanuy, Ignacio Cidraque, Rosemarie Preyer, Kevin Strecker, Juan J. Lozano, Daniel Podzamczer, Elena Crespo, Oriol Bestard |
| 69 |
[GO] |
2022―Jun―22 |
High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2 |
Valérie Pourcher, Lisa Belin, Cathia Soulie, Michelle Rosenzwajg, Stéphane Marot, Karine Lacombe, Nadia Valin, Gilles Pialoux, Ruxandra Calin, Christia Palacios, Isabelle Malet, Karen Zafilaza, Roland Tubiana, Marc-Antoine Valantin, David Klatzmann, Vincent Calvez, Noémie Simon-Tillaux, Anne-Geneviève Marcelin |
| 70 |
[GO] |
2022―Apr―25 |
Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine |
Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Chris K.P. Mok, David S.C. Hui, Shui Shan Lee, Denise P.C. Chan |
| 71 |
[GO] |
2022―Mar―24 |
Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications |
Alejandro R. Gener, Shyam Kottilil |
| 72 |
[GO] |
2022―Mar―24 |
Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV |
Rocio Montejano, Cristina Marcelo, Iker Falces-Romero, Luis Gonzalez del Valle, Teresa De Soto, Julio Garcia-Rodríguez, Jose R. Arribas |
| 73 |
[GO] |
2022―Feb―24 |
HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors’ reply |
Matthew S. Durstenfeld, Priscilla Y. Hsue |
| 74 |
[GO] |
2022―Jan―27 |
When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV |
Jeffrey J. Post, Thomas Benfield, Ian Woolley |
| 75 |
[GO] |
2022―Jan―27 |
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? |
Xinling Xu, Jan Vesterbacka, Soo Aleman, Piotr Nowak |
| 76 |
[GO] |
2022―Jan―11 |
Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections |
Elisa de Lazzari, Alejandra Martínez-Mimbrero, Iván Chivite, Ana González-Cordón, Maria M. Mosquera, Montserrat Laguno, Josep Costa, Jordi Bosch, Jose L. Blanco, Miriam Álvarez-Martinez, Ainoa Ugarte, Alexy Inciarte, Lorena de la Mora, Berta Torres, Maria Martínez-Rebollar, Juan Ambrosioni, Emma Fernández, Juan Carlos Hurtado, Josep Mallolas, José M. Miró, María A. Marcos, Esteban Martínez |
| 77 |
[GO] |
2022―Jan―11 |
Impaired antibody response to COVID-19 vaccination in advanced HIV infection |
Nolan Hassold, Ségolène Brichler, Elise Ouedraogo, Delphine Leclerc, Sophie Carroue, Yamina Gater, Chakib Alloui, Etienne Carbonnelle, Olivier Bouchaud, Frederic Mechai, Hugues Cordel, Heloise Delagreverie |
| 78 |
[GO] |
2022―Jan―09 |
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV |
Manuel González de Aledo, Angelina Cañizares, Pilar Vázquez-Rodríguez, Ángeles Castro, Luz Moldes, Soledad López, Enrique Míguez, Germán Bou, Álvaro Mena |
| 79 |
[GO] |
2021―Dec―07 |
The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States |
Linda Beer, Yunfeng Tie, Sharoda Dasgupta, Tim McManus, Pranesh P. Chowdhury, John Weiser |
| 80 |
[GO] |
2021―Nov―24 |
SARS-CoV-2 infection and COVID-19 severity in persons with HIV on antiretroviral treatment |
Julia del Amo, Rosa Polo, Santiago Moreno, Inma Jarrín, Miguel A. Hernán |
| 81 |
[GO] |
2021―Nov―09 |
Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19 |
Matthew S. Durstenfeld, Kaiwen Sun, Yifei Ma, Fatima Rodriguez, Eric A. Secemsky, Rushi V. Parikh, Priscilla Y. Hsue |
| 82 |
[GO] |
2021―Nov―01 |
COVID-19 in Africa: preexisting immunity and HIV |
Jumari Snyman, Eduard J. Sanders, Thumbi Ndung’u |
| 83 |
[GO] |
2021―Oct―29 |
Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic |
Walid G. El-Nahal, Nicola M. Shen, Jeanne C. Keruly, Joyce L. Jones, Anthony T. Fojo, Bryan Lau, Yukari C. Manabe, Richard D. Moore, Kelly A. Gebo, Catherine R. Lesko, Geetanjali Chander |
| 84 |
[GO] |
2021―Sep―24 |
SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV |
Matthew A. Spinelli, Lillian B. Brown, David V. Glidden, Kyle Hunter, Patrick Martin-Tuite, James Zheng, Curtis Sera, Diane Havlir, Susan P. Buchbinder, Monica Gandhi |
| 85 |
[GO] |
2021―Sep―02 |
Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response |
Jerilyn R. Hoover, Diana E. Frymus, Temitayo A. Ifafore-Calfee |
| 86 |
[GO] |
2021―Aug―25 |
Covid-19 hospitalization outcomes in persons with and without HIV in SPAIN |
Julián Olalla-Sierra, María Dolores Martín-Escalante, Javier García-Alegría, Manuel Rubio-Rivas, Borja de Miguelcampo, María Zurita-Etayo, Laia Arbones-Fernández, José N. Alcalá-Pedrajas, Alicia Roldán-Silvestre, Begoña Cortés-Rodríguez, José Manuel Casas-Rojo, Jesús Millán Núñez-Cortés |
| 87 |
[GO] |
2021―Aug―25 |
SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020 |
Trevor A. Crowell, Ibrahim I. Daud, Jonah Maswai, John Owuoth, Valentine Sing’oei, Michelle Imbach, Nicole Dear, Fred Sawe, Leigh Anne Eller, Christina S. Polyak, Julie A. Ake |
| 88 |
[GO] |
2021―Aug―16 |
An updated meta-analysis on the association between HIV infection and COVID-19 mortality |
Yadong Wang, Ruo Feng, Jie Xu, Li Shi, Huifen Feng, Haiyan Yang |
| 89 |
[GO] |
2021―Jul―15 |
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV |
Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Christine M. Durand, William A. Werbel |
| 90 |
[GO] |
2021―Jun―29 |
False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection |
Aikaterini Papamanoli, George Psevdos |
| 91 |
[GO] |
2021―Jun―27 |
The challenging of HIV care one year after of COVID-19 pandemic |
Juliane Cardoso Villela Santos, Juliana Schaia Rocha Orsi, Victoria Stadler Ribeiro, Felipe Francisco Tuon, João Paulo Telles |
| 92 |
[GO] |
2021―May―16 |
Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV |
Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Christine M. Durand |
| 93 |
[GO] |
2021―May―11 |
Potential reduction in female sex workers’ risk of contracting HIV during Covid-19 |
Fortunate Machingura, Sungai Chabata, Joanna Busza, Gracious Jamali, Memory Makamba, Jeffrey Dirawo, Raymond Yekeye, Owen Mugurungi, Primrose Matambanadzo, Frances Mary Cowan |
| 94 |
[GO] |
2021―May―04 |
Severe coronavirus disease 2019 in a patient with HIV-2 infection |
Willem J. Wiersinga, Marc van der Valk |
| 95 |
[GO] |
2021―Mar―12 |
Tenofovir-based PrEP for COVID-19 |
Colette DeJong, Matthew A. Spinelli, Hideaki Okochi, Monica Gandhi |
| 96 |
[GO] |
2021―Mar―12 |
Impact of the COVID-19-related global recession on the financing of the global HIV response |
Caroline A. Bulstra, Ché L. Reddy, Rifat Atun, Till Bärnighausen, Jan A.C. Hontelez |
| 97 |
[GO] |
2021―Feb―26 |
Risk of adverse COVID-19 outcomes for people living with HIV |
Maya M. Mellor, Anne C. Bast, Nicholas R. Jones, Nia W. Roberts, José M. Ordóñez-Mena, Alastair J.M. Reith, Christopher C. Butler, Philippa C. Matthews, Jienchi Dorward |
| 98 |
[GO] |
2020―Dec―30 |
Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa |
Kadimo Nthobatsang, Tshimologo Lone Ncenga, Chipo Mwangi-Woto, Tuelo J. Wedu, Tebogo Gabatlhaolwe, Sikhulile Moyo, Richard Marlink, Ishmael Kasvosve, Lesego Gabaitiri, Modisa S. Motswaledi |
| 99 |
[GO] |
2020―Dec―10 |
Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP) |
Matthew D. Hickey, Elizabeth Imbert, David V. Glidden, Jan Bing Del Rosario, Mary Chong, Angelo Clemenzi-Allen, Jon Oskarsson, Elise D. Riley, Monica Gandhi, Diane V. Havlir |
| 100 |
[GO] |
2020―Dec―01 |
Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions |
Michael W. Traeger, Prital Patel, Rebecca Guy, Margaret E. Hellard, Mark A. Stoové |
| 101 |
[GO] |
2020―Nov―29 |
Caring for people living with HIV during the global COVID-19 pandemic |
Olivier Nawej Tshikung, Mikaela Smit, Annalisa Marinosci, Hélène Buvelot, Pablo Valladares, Thanh Do-Co Lecompte, Yvonne Flammer, Alexandra Calmy |
| 102 |
[GO] |
2020―Nov―08 |
The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings |
Lauren F. Collins, Jonathan A. Colasanti, Minh Ly Nguyen, Caitlin A. Moran, Cecile D. Lahiri, Vince C. Marconi, Wendy S. Armstrong, N. Sarita Shah |
| 103 |
[GO] |
2020―Sep―09 |
Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19 |
Matthew A. Spinelli, Matthew D. Hickey, David V. Glidden, Janet Q. Nguyen, Jon J. Oskarsson, Diane Havlir, Monica Gandhi |
| 104 |
[GO] |
2020―Sep―09 |
Persons living with HIV may be reluctant to access to COVID-19 testing services |
Francesco Maria Fusco, Vincenzo Sangiovanni, Claudia Tiberio, Nunzia Papa, Luigi Atripaldi, Vincenzo Esposito |
| 105 |
[GO] |
2020―Aug―31 |
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? |
Antonio Di Biagio, Lucia Taramasso, Chiara Dentone, Antonio Vena, Daniele R. Giacobbe, Andrea De Maria, Malgorzata Mikulska, Matteo Bassetti |
| 106 |
[GO] |
2020―Aug―13 |
Factors associated with hospital admission for COVID-19 in HIV patients |
Antonio Di Biagio, Elena Ricci, Leonardo Calza, Nicola Squillace, Barbara Menzaghi, Stefano Rusconi, Giancarlo Orofino, Olivia Bargiacchi, Chiara Molteni, Laura Valsecchi, Giovanni Cenderello, Sergio Ferrara, Annalisa Saracino, Paolo Maggi, Katia Falasca, Lucia Taramasso, Paolo Bonfanti |
| 107 |
[GO] |
2020―Aug―13 |
Characteristics and outcomes of COVID-19 in patients with HIV |
Yousaf B. Hadi, Syeda F.Z. Naqvi, Justin T. Kupec, Arif R. Sarwari |
| 108 |
[GO] |
2020―Aug―10 |
HIV infection and COVID-19 |
Nicolas Etienne, Marina Karmochkine, Laurence Slama, Juliette Pavie, Dominique Batisse, Rafael Usubillaga, Valerie-Anne Letembet, Patricia Brazille, Etienne Canouï, Dorsaf Slama, Hassan Joumaa, Florence Canoui-Poitrine, Lauriane Segaux, Laurence Weiss, Jean-Paul Viard, Dominique Salmon |
| 109 |
[GO] |
2020―Aug―10 |
Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV |
Alexy Inciarte, Ana Gonzalez-Cordon, Jhon Rojas, Berta Torres, Elisa de Lazzari, Lorena de la Mora, Maria Martinez-Rebollar, Montserrat Laguno, Pilar Callau, Azucena Gonzalez-Navarro, Lorna Leal, Felipe Garcia, Josep Mallolas, Mar Mosquera, Maria A. Marcos, Juan Ambrosioni, Josep M. Miro, Esteban Martinez, Jose L. Blanco |
| 110 |
[GO] |
2020―Aug―04 |
Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn |
Lolita Sasset, Eugenia Di Meco, Silvia Cavinato, Anna M. Cattelan |
| 111 |
[GO] |
2020―Aug―04 |
Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain |
Estibaliz Molina-Iturritza, Irene San-José-Muñiz, Maite Ganchegui-Aguirre, Leire Balerdi-Sarasola, Zuriñe Ortiz-de-Zárate-Ibarra, Juan C. Gainzarain-Arana, Joseba Portu-Zapirain |
| 112 |
[GO] |
2020―Jul―23 |
COVID-19 attack rate in HIV-infected patients and in PrEP users |
Caroline Charre, Vinca Icard, Pierre Pradat, Corinne Brochier, Bruno Lina, Christian Chidiac, Laurent Cotte |
| 113 |
[GO] |
2020―Jul―23 |
Preserving two decades of healthcare gains for africa in the Covid-19 era |
Sonak D. Pastakia, Paula Braitstein, Omar Galárraga, Becky Genberg, Jamil Said, Rajesh Vedanthan, Juddy Wachira, Joseph W. Hogan |
| 114 |
[GO] |
2020―Jul―23 |
Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes |
Alan Winston, Davide De Francesco, Frank Post, Marta Boffito, Jaime Vera, Ian Williams, Jane Anderson, Patrick W.G. Mallon, Caroline A. Sabin |
| 115 |
[GO] |
2020―Jul―16 |
Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA |
Lauren F. Collins, Caitlin A. Moran, Nora T. Oliver, Abeer Moanna, Cecile D. Lahiri, Jonathan A. Colasanti, Colleen F. Kelley, Minh Ly Nguyen, Vincent C. Marconi, Wendy S. Armstrong, Ighovwerha Ofotokun, Anandi N. Sheth |
| 116 |
[GO] |
2020―Jul―16 |
What one pandemic can teach us in facing another |
Wafaa M. El-Sadr |
| 117 |
[GO] |
2020―Jun―30 |
Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV |
Eric A. Meyerowitz, Arthur Y. Kim, Kevin L. Ard, Nesli Basgoz, Jacqueline T. Chu, Rocio M. Hurtado, Catherine K. Lee, Wei He, Theresa Minukas, Sandra Nelson, Bisola O. Ojikutu, Greg Robbins, Sarimer Sanchez, Virginia A. Triant, Kimon Zachary, Rajesh T. Gandhi |
| 118 |
[GO] |
2020―Jun―23 |
Cases of coronavirus disease-2019 in HIV-infected transgender women |
Eisuke Adachi, Makoto Saito, Kazuhiko Ikeuchi, Tokio Hoshina, Hiroshi Yotsuyanagi |
| 119 |
[GO] |
2020―Jun―03 |
Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics |
Nicolas Dauby |
| 120 |
[GO] |
2020―Jun―03 |
Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV |
Harry Coleman, Luke B. Snell, Rebecca Simons, Sam T. Douthwaite, Ming J. Lee |
| 121 |
[GO] |
2020―Jun―03 |
SARS-CoV-2 infection in a highly experienced person living with HIV |
Simona Di Giambenedetto, Paola Del Giacomo, Arturo Ciccullo, Angelo Porfidia, Giuseppe De Matteis, Rossella Cianci, Francesco De Vito, Alex Dusina, Alberto Borghetti, Mario Tumbarello |
| 122 |
[GO] |
2020―Apr―19 |
Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome |
Junwei Su, Xiaomin Shen, Qin Ni, Hong Zhao, Jieru Cai, Biao Zhu, Wenrui Wu, Guanjing Lang, Kaijin Xu, Jifang Sheng |
|
